DDrare: Database of Drug Development for Rare Diseases

Oxandrolone (DrugBank: Oxandrolone)

2 diseases

ID	Disease name (Link within this page)	Number of trials
211	Hypoplastic left heart syndrome	1
285	Fanconi anemia	1

211. Hypoplastic left heart syndrome [ 20 clinical trials, 28 drugs, (DrugBank: 9 drugs), 5 drug target genes, 13 drug target pathways]

Searched query = "Hypoplastic left heart syndrome", "HLHS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 20 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04090697 (ClinicalTrials.gov)	December 20, 2019	4/4/2019	Use of Oxandrolone to Promote Growth in Infants With HLHS	Use of Oxandrolone to Promote Growth in Infants With Hypoplastic Left Heart Syndrome: A Phase I/II Pilot Study	Hypoplastic Left Heart;Congenital Heart Disease	Drug: Oxandrolone	HealthCore-NERI	NULL	Recruiting	N/A	14 Days	All	100	Phase 1;Phase 2	United States;Canada

285. Fanconi anemia [ 56 clinical trials, 111 drugs, (DrugBank: 31 drugs), 30 drug target genes, 151 drug target pathways]

Searched query = "Fanconi anemia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 56 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00243399 (ClinicalTrials.gov)	July 2004	20/10/2005	Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia	A Pilot Trial of Oxandrolone for the Treatment of Bone Marrow Aplasia in Patients With Fanconi Anemia	Fanconi Anemia	Drug: Oxandrolone	Children's Hospital Medical Center, Cincinnati	FDA Office of Orphan Products Development	Completed	N/A	N/A	Both	10	Phase 1	United States